CASU, Cinzia
 Distribuzione geografica
Continente #
EU - Europa 525
NA - Nord America 508
AS - Asia 197
OC - Oceania 5
Totale 1.235
Nazione #
US - Stati Uniti d'America 505
DE - Germania 195
UA - Ucraina 135
CN - Cina 105
IT - Italia 79
HK - Hong Kong 36
SG - Singapore 34
RU - Federazione Russa 32
FI - Finlandia 29
FR - Francia 19
GB - Regno Unito 17
IE - Irlanda 16
TR - Turchia 16
AU - Australia 5
CA - Canada 2
AT - Austria 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
JM - Giamaica 1
JP - Giappone 1
KR - Corea 1
PH - Filippine 1
RS - Serbia 1
SE - Svezia 1
Totale 1.235
Città #
Woodbridge 96
Jacksonville 80
Houston 47
Fairfield 45
Hong Kong 36
Princeton 32
Singapore 25
Ann Arbor 21
Cambridge 21
Nanjing 21
Dublin 16
Istanbul 16
Wilmington 16
Ashburn 15
Beijing 15
Helsinki 13
Seattle 13
Lancaster 11
Nanchang 10
New York 10
Nürnberg 10
Milan 9
Shenyang 9
Des Moines 8
Shanghai 8
Changsha 7
Hebei 7
Siena 6
Chandler 5
Hangzhou 4
Jinan 4
San Diego 4
Dearborn 3
Florence 3
Haikou 3
Jiaxing 3
Kunming 3
London 3
Melbourne 3
Solarussa 3
Verona 3
Bergamo 2
Fuzhou 2
Genova 2
Hanover 2
Lanzhou 2
Rome 2
Strasbourg 2
Tianjin 2
Toronto 2
Arbil 1
Ardabil 1
Bacoli 1
Cagliari 1
Canberra 1
Ceriale 1
Como 1
Ferrara 1
Naples 1
Nettuno 1
Ningbo 1
Norwalk 1
Pesaro 1
Pescara 1
Quartu Sant'elena 1
Ramon 1
San Francisco 1
Sydney 1
Udine 1
Vienna 1
Zhengzhou 1
Totale 706
Nome #
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI E LESIONI PUNTIFORMI DELLA SOSTANZA BIANCA ALLA RISONANZA MAGNETICA. QUAL E' IL LORO SIGNIFICATO? VALUTAZIONE DI 169 PAZIENTI CON MANIFESTAZIONI NEUROLOGICHE 164
Antiphospholipid antibody profile: implications for the evaluation and management of patients. 109
PROSPECTIVELY FOLLOWED PREGNANCIES IN PATIENTS WITH SYSTEMIC VASCULITIS: STILL MANY PROBLEMS ON BOTH FOETAL AND MATERNAL SIDE 100
Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations 98
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients 96
RECURRENCE OF THROMBOTIC EVENTS IN YOUNG PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME RELATED WITH TRIPLE POSITIVITY FOR ANTIPHOSPHOLIPD ANTIBODIES 76
EVALUATION OF NEUROLOGICAL MANIFESTATIONS IN 180 PATIENTS (PTS) WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME (PAPS) 73
RELATIONSHIP BETWEEN SLE SUSCEPTIBILITY GENES AND CLINICAL MANIFESTATIONS IN A COHORT OF PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME 72
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA: FOCUS SULLE MANIFESTAZIONI NEUROLOGICHE 67
IL "PROFILO" DEGLI ANTICORPI ANTIFOSFOLIPIDI NELLA SINDROME PRIMARIA COME FATTORE DI RISCHIO PER EVENTI CLINICI: STUDIO DI 175 PAZIENTI 63
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA E LUPUS ERITEMATOSO SISTEMICO: DIFFERENZE E SOMIGLIANZE GENETIHE 62
MANIFESTAZIONI NEUROLOGICHE IN 180 PAZIENTI CON SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA. RUOLO DEI FATTORI DI RISCHIO CARDIOVASCOLARI 62
SICUREZZA DEI FARMACI BIOLOGICI ANTI-TNF IN GRAVIDANZA 54
ATTRIBUTION OF NEUROPSYCHIATRIC EVENTS IN SLE: VALIDATION OF AN ALGORITHM ON AN EXTERNAL MULTICENTER COHORT 49
RISK FACTORS AND CO-MORBIDITIES ASSOCIATED WITH NEURO-PSYCHIATRIC INVOLVEMENT IN SLE: A SUB-ANALYSIS IN 413 PATIENS WITHOUT ANTIPHOSPHIOLIPID ANTIBODIES 49
RISK FACTORS AND CO-MORBIDITIES ASSOCIATED WITH NEURO-PSYCHIATRIC INVOLVEMENT IN SLE: A RETROSPECTIVE MULTICENTRIC STUDY ON A LARGE COHORT OF 959 ITALIAN PATIENTS 49
Totale 1.243
Categoria #
all - tutte 5.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.221


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020149 0 0 0 0 8 24 10 24 8 43 13 19
2020/2021178 2 22 3 22 10 22 4 24 33 14 20 2
2021/2022102 2 20 3 3 1 2 3 6 3 15 10 34
2022/202384 16 0 3 2 1 20 0 9 15 0 9 9
2023/2024111 9 9 14 3 3 10 3 0 36 0 0 24
2024/202554 2 0 0 34 18 0 0 0 0 0 0 0
Totale 1.243